Digital pathology access and usage in the UK: results from a national survey on behalf of the National Cancer Research Institute’s CM-Path initiative

Author:

Williams Bethany Jill,Lee Jessica,Oien Karin A,Treanor Darren

Abstract

AimTo canvass the UK pathology community to ascertain current levels of digital pathology usage in clinical and academic histopathology departments, and prevalent attitudes to digital pathology.MethodsA 15-item survey was circulated to National Health Service and academic pathology departments across the UK using the SurveyMonkey online survey tool. Responses were sought at a departmental or institutional level. Where possible, departmental heads were approached and asked to complete the survey, or forward it to the most relevant individual in their department. Data were collected over a 6-month period from February to July 2017.Results41 institutes from across the UK responded to the survey. 60% (23/39) of institutions had access to a digital pathology scanner, and 60% (24/40) had access to a digital pathology workstation. The most popular applications of digital pathology in current use were undergraduate and postgraduate teaching, research and quality assurance. Investigating the deployment of digital pathology in their department was identified as a high or highest priority by 58.5% of institutions, with improvements in efficiency, turnaround times, reporting times and collaboration in their institution anticipated by the respondents. Access to funding for initial hardware, software and staff outlay, pathologist training and guidance from the Royal College of Pathologists were identified as factors that could enable respondent institutions to increase their digital pathology usage.ConclusionInterest in digital pathology adoption in the UK is high, with usage likely to increase in the coming years. In light of this, pathologists are seeking more guidance on safe usage.

Publisher

BMJ

Subject

General Medicine,Pathology and Forensic Medicine

Reference8 articles.

1. Telepathology: current status and future prospects in diagnostic histopathology

2. Food and Drug Administration. FDA allows marketing of first whole slide imaging system for digital pathology. Press release 2017. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm552742.htm (accessed 8 Apr 2017).

3. Future-proofing pathology: the case for clinical adoption of digital pathology

4. Cancer Research Uk. Testing times to come? An evaluation of pathology capacity across the UK. http://www.cancerresearchuk.org/sites/default/files/testing_times_to_come_nov_16_cruk.pdf (accessed 10 Feb 2017).

5. The diagnostic concordance of whole slide imaging and light microscopy: a systematic review;Goacher;Arch Pathol Lab Med,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3